HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Omaima Nasif Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

1/2021Phyllanthin Averts Oxidative Stress and Neuroinflammation in Cerebral Ischemic-Reperfusion Injury through Modulation of the NF-κB and AMPK/Nrf2 Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Omaima Nasif Research Topics

Disease

2Dehydration (Water Stress)
01/2022 - 11/2021
1Multiple Myeloma
07/2021
1Colorectal Neoplasms (Colorectal Cancer)
05/2021
1COVID-19
05/2021
1Fibrosis (Cirrhosis)
01/2021
1Inflammation (Inflammations)
01/2021
1Reperfusion Injury
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021
1Neuroinflammatory Diseases
01/2021
1Brain Edema (Cerebral Edema)
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
01/2020
1Osteoporosis
01/2020

Drug/Important Bio-Agent (IBA)

1EnzymesIBA
01/2022
1NitrogenIBA
01/2022
1ChlorophyllIBA
01/2022
1biocharIBA
01/2022
1KaolinIBA
11/2021
1jasmonic acid (jasmonate)IBA
11/2021
1dehydroabietylamineIBA
07/2021
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
07/2021
1Biomarkers (Surrogate Marker)IBA
05/2021
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2021
1EucalyptolIBA
05/2021
1Peptide Hydrolases (Proteases)FDA Link
05/2021
1Volatile Oils (Essential Oils)IBA
05/2021
1Transaminases (Aminotransferases)IBA
01/2021
1Alanine Transaminase (SGPT)IBA
01/2021
1salicylhydroxamic acid (SHAM)IBA
01/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1phyllanthinIBA
01/2021
1Dinoprostone (PGE2)FDA Link
01/2021
1Biocompatible Materials (Biomaterials)IBA
01/2020

Therapy/Procedure

1Therapeutics
05/2021